Company
Axelyf
Also known as Axelyf, Inc
- Business model
- B2B
- Legal name
- Axelyf, Inc
Claim, correct or request removal
Record updated 23 October 2026
About
Developing the Next Generation of RNA Medicines.
Funding snapshot
- Total raised
- $4.8MSEC form D sum, as of 2026-09-29Source (opens in a new tab)
- Latest round
- Undisclosed, $2.6M2026-10-07
Funding rounds
- Round, 2026
- $2.6M2026-10-07, SEC form D sold
- Round, 2025
- $4.8M2025-07-25, SEC form D sold, 37 investors
Loading relationship preview